These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 16775010

  • 21. Phosphatidylinositol 3-kinase and Rab5 GTPase inversely regulate the Smad anchor for receptor activation (SARA) protein independently of transforming growth factor-β1.
    Runyan CE, Liu Z, Schnaper HW.
    J Biol Chem; 2012 Oct 19; 287(43):35815-24. PubMed ID: 22942286
    [Abstract] [Full Text] [Related]

  • 22. Cooperation of H2O2-mediated ERK activation with Smad pathway in TGF-beta1 induction of p21WAF1/Cip1.
    Kim YK, Bae GU, Kang JK, Park JW, Lee EK, Lee HY, Choi WS, Lee HW, Han JW.
    Cell Signal; 2006 Feb 19; 18(2):236-43. PubMed ID: 15979845
    [Abstract] [Full Text] [Related]

  • 23. Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling.
    Dai C, Yang J, Liu Y.
    J Biol Chem; 2003 Apr 04; 278(14):12537-45. PubMed ID: 12560323
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Focal adhesion molecule Kindlin-1 mediates activation of TGF-β signaling by interacting with TGF-βRI, SARA and Smad3 in colorectal cancer cells.
    Kong J, Du J, Wang Y, Yang M, Gao J, Wei X, Fang W, Zhan J, Zhang H.
    Oncotarget; 2016 Nov 15; 7(46):76224-76237. PubMed ID: 27776350
    [Abstract] [Full Text] [Related]

  • 26. SMURF2 and SMAD7 induce SARA degradation via the proteasome.
    Wojtowicz S, Lee S, Chan E, Ng E, Campbell CI, Di Guglielmo GM.
    Cell Signal; 2020 Aug 15; 72():109627. PubMed ID: 32283253
    [Abstract] [Full Text] [Related]

  • 27. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways.
    Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I.
    J Cell Biochem; 2005 Aug 01; 95(5):918-31. PubMed ID: 15861394
    [Abstract] [Full Text] [Related]

  • 28. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.
    Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL.
    Cell; 1998 Dec 11; 95(6):779-91. PubMed ID: 9865696
    [Abstract] [Full Text] [Related]

  • 29. The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-beta/Smad signalling.
    Itoh F, Divecha N, Brocks L, Oomen L, Janssen H, Calafat J, Itoh S, Dijke Pt Pt.
    Genes Cells; 2002 Mar 11; 7(3):321-31. PubMed ID: 11918675
    [Abstract] [Full Text] [Related]

  • 30. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G, Komuro A, Goto K, Shinozaki M, Miyazawa K, Miyazono K, Imamura T.
    Biochem J; 2005 Mar 15; 386(Pt 3):461-70. PubMed ID: 15496141
    [Abstract] [Full Text] [Related]

  • 31. Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis.
    Zhao J, Crowe DL, Castillo C, Wuenschell C, Chai Y, Warburton D.
    Mech Dev; 2000 May 15; 93(1-2):71-81. PubMed ID: 10781941
    [Abstract] [Full Text] [Related]

  • 32. Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes.
    Altomare D, Velidandla R, Pirisi L, Creek KE.
    BMC Cancer; 2013 Sep 18; 13():424. PubMed ID: 24047375
    [Abstract] [Full Text] [Related]

  • 33. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.
    Daly AC, Randall RA, Hill CS.
    Mol Cell Biol; 2008 Nov 18; 28(22):6889-902. PubMed ID: 18794361
    [Abstract] [Full Text] [Related]

  • 34. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
    Hayashida T, Decaestecker M, Schnaper HW.
    FASEB J; 2003 Aug 18; 17(11):1576-8. PubMed ID: 12824291
    [Abstract] [Full Text] [Related]

  • 35. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP.
    Cui Q, Lim SK, Zhao B, Hoffmann FM.
    Oncogene; 2005 Jun 02; 24(24):3864-74. PubMed ID: 15750622
    [Abstract] [Full Text] [Related]

  • 36. Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype.
    Runyan CE, Hayashida T, Hubchak S, Curley JF, Schnaper HW.
    J Biol Chem; 2009 Sep 11; 284(37):25181-9. PubMed ID: 19620243
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of the transforming growth factor-beta/Smad signaling pathway in the epithelium of oral lichen.
    Karatsaidis A, Schreurs O, Axéll T, Helgeland K, Schenck K.
    J Invest Dermatol; 2003 Dec 11; 121(6):1283-90. PubMed ID: 14675171
    [Abstract] [Full Text] [Related]

  • 38. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
    Baldwin RL, Tran H, Karlan BY.
    Cancer Res; 2003 Mar 15; 63(6):1413-9. PubMed ID: 12649207
    [Abstract] [Full Text] [Related]

  • 39. Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.
    Choi K, Lee K, Ryu SW, Im M, Kook KH, Choi C.
    Mol Vis; 2012 Mar 15; 18():1010-20. PubMed ID: 22550395
    [Abstract] [Full Text] [Related]

  • 40. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P.
    EMBO J; 1997 Sep 01; 16(17):5353-62. PubMed ID: 9311995
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.